The state of Kansas will receive over $45 million total from two pharmaceutical companies as the state’s fight against opioid abuse continues.
Outgoing Attorney General Derek Schmidt says Teva has agreed to pay nearly $29 million. Part of that particular settlement involves Teva agreeing to stop promoting or lobbying for opioid products. Teva also has to monitor and report “off-label” use of fentanyl-based products, share clinical data through and disclose records to a third-party entity and pay for an independent agency to ensure compliance.
Allergan, meanwhile, is paying almost $17 million and is leaving the opioid market altogether.
With this announcement, the Office of Attorney General has worked to reach settlements with nearly 10 different pharmaceutical or pharmacy companies:
*Cardinal Health, Inc., McKesson Corporation, and AmerisourceBergen Corporation (distributors) – $153,002,437.92
*Johnson & Johnson – $35,184,155.44
*Teva – $28,405,105.74
*Allergan – $16,909,682.36
*McKinsey & Company – $4,805,800.46
*CVS Pharmacy – $37,416,332.23
*Walgreens Pharmacy – $40,695,230.06
*Walmart Pharmacy – $21,190,065.47
*Mallinckrodt – at least $6 million
Proceeds from all the agreements secured over the past year are used to provide treatment and recovery services.
